3854-90-8

Usage

InChI:InChI=1/C11H14O2/c1-3-8-5-9(4-2)7-10(6-8)11(12)13/h5-7H,3-4H2,1-2H3,(H,12,13)

Upstream product

• 105905-71-3 3,5-diethyl-benzonitrile 
• 81698-95-5 3,5-diethylbenzaldehyde 
• 52095-17-7 3′,5′-diethylacetophenone 
• 102-25-0 1,3,5-triethylbenzene 
• 7697-37-2 nitric acid 
• 57361-89-4 1-(1-Bromo-ethyl)-3,5-diethyl-benzene 
• 198623-52-8 1-(3,5-diethyl-phenyl)ethanol 
• 33696-10-5 2,4-diethyl-1-nitro-benzene 
• 90267-03-1 1-bromo-3,5-diethylbenzene 
• 210414-88-3 2,4-diethyl-6-bromo-aniline 
• 14719-47-2 2,4-dimethylmethylaniline 

Downstream Products

• 198623-53-9 (3,5-diethylphenyl)methanol 
• 198623-54-0 (3,5-Diethyl-phenyl)-acetonitrile 

Relevant academic research and scientific papers

Inclusion complex containing epoxy resin composition for semiconductor encapsulation

The invention is an epoxy resin composition for sealing a semiconductor, including (A) an epoxy resin and (B) a clathrate complex. The clathrate complex is one of (b1) an aromatic carboxylic acid compound, and (b2) at least one imidazole compound represented by formula (II): wherein R2 represents a hydrogen atom, C1-C10 alkyl group, phenyl group, benzyl group or cyanoethyl group, and R3 to R5 represent a hydrogen atom, nitro group, halogen atom, C1-C20 alkyl group, phenyl group, benzyl group, hydroxymethyl group or C1-C20 acyl group. The composition has improved storage stability, retains flowability when sealing, and achieves an effective curing rate applicable for sealing delicate semiconductors.

Discovery and structure-activity studies of a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors

The inhibition of tyrosine kinase-mediated signal transduction pathways represents a therapeutic approach to the intervention of proliferative diseases such as cancer, atherosclerosis, and restenosis. A novel series of pyrido[2,3-d]pyrimidine inhibitors of the PDGFr, bFGFr, and c-Src tyrosine kinases was developed from compound library screening and lead optimization.' In addition, highly selective inhibitors of the FGFr tyrosine kinase were also discovered and developed from this novel series of pyrido[2,3-d]pyrimidines. The syntheses, biological evaluation, and structure-activity relationships of this series are reported.